Zobrazeno 1 - 10
of 1 655
pro vyhledávání: '"Lindfors L"'
Autor:
Payandeh Z; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41346, Sweden., Tangruksa B; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41346, Sweden; Systems Biology Research Center, School of Bioscience, University of Skövde, 541 28, Skövde, Sweden., Synnergren J; Systems Biology Research Center, School of Bioscience, University of Skövde, 541 28, Skövde, Sweden; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41345, Sweden., Heydarkhan-Hagvall S; Systems Biology Research Center, School of Bioscience, University of Skövde, 541 28, Skövde, Sweden; Global Patient Safety - Biopharma, AstraZeneca, 431 83, Gothenburg, Mölndal, Sweden., Nordin JZ; Division of Biomolecular and Cellular Medicine, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden., Andaloussi SE; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Borén J; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden., Wiseman J; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, 431 83, Gothenburg, Mölndal, Sweden., Bohlooly-Y M; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, 431 83, Gothenburg, Mölndal, Sweden., Lindfors L; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, 431 83, Mölndal, Sweden., Valadi H; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41346, Sweden. Electronic address: hadi.valadi@gu.se.
Publikováno v:
Molecular aspects of medicine [Mol Aspects Med] 2024 Oct; Vol. 99, pp. 101302. Date of Electronic Publication: 2024 Aug 01.
Publikováno v:
In Agricultural and Forest Meteorology 15 July 2019 272-273:20-29
Autor:
Aliakbarinodehi N; Department of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden., Niederkofler S; Department of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden., Emilsson G; Advanced Drug Delivery, Pharmaceutical Sciences, AstraZeneca R&D, Mölndal 43181, Sweden., Parkkila P; Department of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden., Olsén E; Department of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden., Jing Y; Advanced Drug Delivery, Pharmaceutical Sciences, AstraZeneca R&D, Mölndal 43181, Sweden., Sjöberg M; Department of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden., Agnarsson B; Department of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden., Lindfors L; Advanced Drug Delivery, Pharmaceutical Sciences, AstraZeneca R&D, Mölndal 43181, Sweden., Höök F; Department of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden.
Publikováno v:
ACS nano [ACS Nano] 2024 Aug 27; Vol. 18 (34), pp. 22989-23000. Date of Electronic Publication: 2024 Aug 12.
Autor:
Tesei G; Structural Biology and NMR Laboratory & The Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen DK-2200, Denmark.; Department of Chemistry, Division of Computational Chemistry, Lund University, Lund SE-221 00, Sweden., Hsiao YW; The Hartree Centre, Science and Technology Facilities Council (STFC) Daresbury Laboratory, Warrington WA4 4AD, United Kingdom., Dabkowska A; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Grönberg G; Medicinal Chemistry, Early Respiratory & Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Yanez Arteta M; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Ulkoski D; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Bray DJ; The Hartree Centre, Science and Technology Facilities Council (STFC) Daresbury Laboratory, Warrington WA4 4AD, United Kingdom., Trulsson M; Department of Chemistry, Division of Computational Chemistry, Lund University, Lund SE-221 00, Sweden., Ulander J; Data Science and Modelling, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Lund M; Department of Chemistry, Division of Computational Chemistry, Lund University, Lund SE-221 00, Sweden., Lindfors L; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Jan 09; Vol. 121 (2), pp. e2311700120. Date of Electronic Publication: 2024 Jan 04.
Publikováno v:
Annals of Botany, 2014 Dec 01. 114(8), 1711-1718.
Externí odkaz:
https://www.jstor.org/stable/43580019
Autor:
Emilsson G; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 431 83 Gothenburg, Sweden., Liu K; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 431 83 Gothenburg, Sweden., Höök F; Department of Physics, Chalmers University of Technology, 41296 Gothenburg, Sweden., Svensson L; Bioscience Renal In Vivo Research and Early Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, 431 83 Gothenburg, Sweden., Rosengren L; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, 431 83 Gothenburg, Sweden., Lindfors L; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 431 83 Gothenburg, Sweden., Sigfridsson K; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 431 83 Gothenburg, Sweden.
Publikováno v:
ACS nano [ACS Nano] 2023 Dec 26; Vol. 17 (24), pp. 24725-24742. Date of Electronic Publication: 2023 Dec 13.
Autor:
Philipp J; Faculty of Physics and Center for NanoScience, Ludwig Maximilians-University, Munich 80539, Germany., Dabkowska A; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Reiser A; Faculty of Physics and Center for NanoScience, Ludwig Maximilians-University, Munich 80539, Germany., Frank K; Faculty of Physics and Center for NanoScience, Ludwig Maximilians-University, Munich 80539, Germany., Krzysztoń R; Faculty of Physics and Center for NanoScience, Ludwig Maximilians-University, Munich 80539, Germany., Brummer C; Faculty of Physics and Center for NanoScience, Ludwig Maximilians-University, Munich 80539, Germany., Nickel B; Faculty of Physics and Center for NanoScience, Ludwig Maximilians-University, Munich 80539, Germany., Blanchet CE; European Molecular Biology Laboratory Hamburg Outstation c/o Deutsches Elektronen-Synchrotron, Hamburg 22607, Germany., Sudarsan A; Institute of Physics, University of Augsburg, Augsburg 86159, Germany., Ibrahim M; Institute of Physics, University of Augsburg, Augsburg 86159, Germany., Johansson S; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Skantze P; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Skantze U; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Östman S; Animal Sciences and Technologies, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Johansson M; Animal Sciences and Technologies, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Henderson N; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Elvevold K; Marine Biotechnology, Nofima AS, Tromsø 9291, Norway., Smedsrød B; Vascular Biology Research Group, Department of Medical Biology, University of Tromsø, Tromsø 9019, Norway., Schwierz N; Institute of Physics, University of Augsburg, Augsburg 86159, Germany., Lindfors L; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden., Rädler JO; Faculty of Physics and Center for NanoScience, Ludwig Maximilians-University, Munich 80539, Germany.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Dec 12; Vol. 120 (50), pp. e2310491120. Date of Electronic Publication: 2023 Dec 06.
Autor:
Nawaz M; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41346, Sweden., Heydarkhan-Hagvall S; BioPharmaceuticals R&D, Early Cardiovascular, Renal and Metabolism (CVRM), Bioscience Cardiovascular, AstraZeneca, Gothenburg, Mölndal, 43183, Sweden.; Systems Biology Research Center, School of Bioscience, University of Skövde, Skövde, SE-54128, Sweden., Tangruksa B; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41346, Sweden.; Systems Biology Research Center, School of Bioscience, University of Skövde, Skövde, SE-54128, Sweden., González-King Garibotti H; BioPharmaceuticals R&D, Early Cardiovascular, Renal and Metabolism (CVRM), Bioscience Cardiovascular, AstraZeneca, Gothenburg, Mölndal, 43183, Sweden., Jing Y; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Mölndal, 43183, Sweden., Maugeri M; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41346, Sweden.; Safety Innovations, Clinical Pharmacology and Safety Sciences, R&D AstraZeneca, Gothenburg, Mölndal, 43183, Sweden., Kohl F; BioPharmaceuticals R&D, Discovery Sciences, Translational Genomics, AstraZeneca, Gothenburg, Mölndal, 43183, Sweden.; Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Stockholm, 17177, Sweden., Hultin L; BioPharmaceuticals R&D, Clinical Pharmacology and Safety Science, Imaging and Data Analytics, AstraZeneca, Gothenburg, Mölndal, 43183, Sweden., Reyahi A; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41346, Sweden., Camponeschi A; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41346, Sweden., Kull B; BioPharmaceuticals R&D, Early Cardiovascular, Renal and Metabolism (CVRM), Bioscience Cardiovascular, AstraZeneca, Gothenburg, Mölndal, 43183, Sweden., Christoffersson J; BioPharmaceuticals R&D, Early Cardiovascular, Renal and Metabolism (CVRM), Bioscience Cardiovascular, AstraZeneca, Gothenburg, Mölndal, 43183, Sweden.; Systems Biology Research Center, School of Bioscience, University of Skövde, Skövde, SE-54128, Sweden., Grimsholm O; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41346, Sweden.; Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, 1090, Austria., Jennbacken K; BioPharmaceuticals R&D, Early Cardiovascular, Renal and Metabolism (CVRM), Bioscience Cardiovascular, AstraZeneca, Gothenburg, Mölndal, 43183, Sweden., Sundqvist M; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41346, Sweden., Wiseman J; BioPharmaceuticals R&D, Discovery Sciences, Translational Genomics, AstraZeneca, Gothenburg, Mölndal, 43183, Sweden., Bidar AW; BioPharmaceuticals R&D, Discovery Sciences, Translational Genomics, AstraZeneca, Gothenburg, Mölndal, 43183, Sweden., Lindfors L; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Mölndal, 43183, Sweden., Synnergren J; Systems Biology Research Center, School of Bioscience, University of Skövde, Skövde, SE-54128, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41345, Sweden., Valadi H; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41346, Sweden.
Publikováno v:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2023 Apr; Vol. 10 (12), pp. e2206187. Date of Electronic Publication: 2023 Feb 19.
Autor:
Dimiou S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D AstraZeneca, Granta Park, CambridgeCB21 6GH, U.K.; UCL School of Pharmacy, 29-39 Brunswick Square, LondonWC1N 1AX, U.K., McCabe J; Early Product Development, Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca, MacclesfieldSK10 2NA, U.K., Booth R; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K., Booth J; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K., Nidadavole K; Early Product Development, Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca, MacclesfieldSK10 2NA, U.K., Svensson O; Pharmaceutical Technology & Development, Operations, AstraZeneca, GothenburgSE-43183, Sweden., Sparén A; Pharmaceutical Technology & Development, Operations, AstraZeneca, GothenburgSE-43183, Sweden., Lindfors L; Advanced Drug Delivery, Pharmaceutical Science, R&D AstraZeneca, GothenburgSE-43183, Sweden., Paraskevopoulou V; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K., Mead H; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K., Coates L; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K., Workman D; Advanced Drug Delivery, Pharmaceutical Sciences, R&D AstraZeneca, Granta Park, CambridgeCB21 6GH, U.K., Martin D; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K., Treacher K; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K., Puri S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D AstraZeneca, Granta Park, CambridgeCB21 6GH, U.K., Taylor LS; Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana47907, United States., Yang B; Advanced Drug Delivery, Pharmaceutical Sciences, R&D AstraZeneca, Granta Park, CambridgeCB21 6GH, U.K.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2023 Feb 06; Vol. 20 (2), pp. 1138-1155. Date of Electronic Publication: 2023 Jan 18.
Autor:
Aliakbarinodehi N; Division of Nano and Biophysics, Department of Physics, Chalmers University of Technology 41296 Göteborg, Sweden., Gallud A; Division of Chemical Biology, Department of Biology and Biological Engineering, Chalmers University of Technology, 41296 Göteborg, Sweden.; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 43181 Gothenburg, Sweden., Mapar M; Division of Nano and Biophysics, Department of Physics, Chalmers University of Technology 41296 Göteborg, Sweden., Wesén E; Division of Chemical Biology, Department of Biology and Biological Engineering, Chalmers University of Technology, 41296 Göteborg, Sweden., Heydari S; Division of Chemical Biology, Department of Biology and Biological Engineering, Chalmers University of Technology, 41296 Göteborg, Sweden., Jing Y; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 43181 Gothenburg, Sweden., Emilsson G; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 43181 Gothenburg, Sweden., Liu K; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 43181 Gothenburg, Sweden., Sabirsh A; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 43181 Gothenburg, Sweden., Zhdanov VP; Division of Nano and Biophysics, Department of Physics, Chalmers University of Technology 41296 Göteborg, Sweden.; Boreskov Institute of Catalysis, Russian Academy of Sciences, Novosibirsk 630090, Russia., Lindfors L; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 43181 Gothenburg, Sweden., Esbjörner EK; Division of Chemical Biology, Department of Biology and Biological Engineering, Chalmers University of Technology, 41296 Göteborg, Sweden., Höök F; Division of Nano and Biophysics, Department of Physics, Chalmers University of Technology 41296 Göteborg, Sweden.
Publikováno v:
ACS nano [ACS Nano] 2022 Dec 27; Vol. 16 (12), pp. 20163-20173. Date of Electronic Publication: 2022 Dec 13.